Filing Details
- Accession Number:
- 0001209191-18-061860
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-10 18:17:28
- Reporting Period:
- 2018-12-07
- Accepted Time:
- 2018-12-10 18:17:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1388658 | Irhythm Technologies Inc. | IRTC | Surgical & Medical Instruments & Apparatus (3841) | 208149544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1670676 | A David Vort | C/O Irhythm Technologies, Inc. 650 Townsend Street, Suite 500 San Francisco CA 94103 | Evp, Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-07 | 4,500 | $3.65 | 26,320 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-12-07 | 5,176 | $73.31 | 21,144 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-12-07 | 4,500 | $0.00 | 4,500 | $3.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 90,794 | 2024-02-04 | No | 4 | M | Direct |
Footnotes
- Includes 323 shares acquired pursuant to the issuer's 2016 Employee Stock Purchase Plan (the "Plan") on June 1, 2018 and 353 shares acquired pursuant to the Plan on December 1, 2018. Reflects a corrective decrease of 1,077 shares resulting from the duplicate reporting in Forms 4 filed September 13, 2017 and March 1, 2018 of 1,077 shares acquired pursuant to the Plan on June 1, 2017.
- This transaction was executed in multiple trades at prices ranging from $73.2836 to $73.4458. The prices reported above reflects the weightedaverage sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of theissuer full information regarding the number of shares and prices at which the transaction was effected.
- The option vested and the shares became exercisable according to the following schedule: 1/4 on January 1, 2015 and 1/36 of the remaining shares on each full calendar month thereafter.
Billionaire Hedge Funds
